documents
Data license: Public Domain (U.S. Government data) · Data source: Federal Register API & Regulations.gov API
96 rows where agency_id = "FDA", document_type = "Rule" and posted_year = 2014 sorted by posted_date descending
This data as json, CSV (advanced)
Suggested facets: subtype, posted_month, comment_end_date, posted_date (date), comment_start_date (date), comment_end_date (date), last_modified (date)
| id | agency_id | docket_id | title | document_type | subtype | posted_date ▲ | posted_year | posted_month | comment_start_date | comment_end_date | last_modified | fr_doc_num | open_for_comment | withdrawn | object_id |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| FDA-2009-F-0303-0031 | FDA | FDA-2009-F-0303 | Food Additives Permitted for Direct Addition to Food for Human Consumption: Advantame | Rule | Final Rule | 2014-12-24T05:00:00Z | 2014 | 12 | 2014-12-24T18:21:53Z | 2014-30144 | 0 | 0 | 0900006481991334 | ||
| FDA-2013-N-1529-0018 | FDA | FDA-2013-N-1529 | Medical Device Classification Procedures: Reclassification Petition: Content and Form; Technical Amendment | Rule | Final Rule | 2014-12-24T05:00:00Z | 2014 | 12 | 2014-12-24T17:15:31Z | 2014-30141 | 0 | 0 | 090000648199128e | ||
| FDA-2011-N-0583-0015 | FDA | FDA-2011-N-0583 | Policy on Orphan-Drug Exclusivity Clarification | Rule | Correction | 2014-12-23T05:00:00Z | 2014 | 12 | 2014-12-23T05:00:00Z | 2014-12-23T14:44:06Z | 2014-29920 | 0 | 0 | 090000648198e7cb | |
| FDA-2014-N-0002-0065 | FDA | FDA-2014-N-0002 | Oral Dosage Form New Animal Drugs; Withdrawal of Approval of New Animal Drug Application; Oxytetracycline | Rule | Withdrawal | 2014-12-15T05:00:00Z | 2014 | 12 | 2014-12-15T05:00:00Z | 2015-03-23T19:19:16Z | 2014-29248 | 0 | 0 | 0900006481976880 | |
| FDA-2014-N-0002-0066 | FDA | FDA-2014-N-0002 | New Animal Drugs; Approval of New Animal Drug Applications; Change of Sponsor; Withdrawal of Approval of New Animal Drug Applications | Rule | Approval | 2014-12-15T05:00:00Z | 2014 | 12 | 2014-12-15T05:00:00Z | 2014-12-16T17:01:04Z | 2014-29249 | 0 | 0 | 09000064819768af | |
| FDA-2000-N-0011-0008 | FDA | Uniform Compliance Date for Food Labeling Regulations FDA-2000-N-0011 | Uniform Compliance Date for Food Labeling Regulations | Rule | Final Rule | 2014-12-10T05:00:00Z | 2014 | 12 | 2014-12-10T05:00:00Z | 2015-02-10T04:59:59Z | 2015-02-03T03:06:32Z | 2014-28829 | 0 | 0 | 090000648196ab7c |
| FDA-2006-N-0515-0068 | FDA | Content and Format of Labeling for Human Prescription Drug and Biological Products; Requirements for Pregnancy and Lactation Labeling FDA-2006-N-0515 | Content and Format of Labeling for Human Prescription Drug and Biological Products; Requirements for Pregnancy and Lactation Labeling | Rule | Final Rule | 2014-12-04T05:00:00Z | 2014 | 12 | 2014-12-04T05:00:00Z | 2014-12-04T15:08:11Z | 2014-28241 | 0 | 0 | 090000648195a53f | |
| FDA-2011-F-0172-0497 | FDA | FDA-2011-F-0172 | Food Labeling; Nutrition Labeling of Standard Menu Items in Restaurants and Similar Retail Food Establishments | Rule | Final Rule | 2014-12-01T05:00:00Z | 2014 | 12 | 2014-12-01T05:00:00Z | 2015-01-01T04:59:59Z | 2015-02-20T19:11:15Z | 2014-27833 | 0 | 0 | 0900006481950b33 |
| FDA-2011-F-0171-0191 | FDA | FDA-2011-F-0171 | Food Labeling; Calorie Labeling of Articles of Food in Vending Machines | Rule | Final Rule | 2014-12-01T05:00:00Z | 2014 | 12 | 2014-12-01T05:00:00Z | 2015-01-01T04:59:59Z | 2015-03-03T03:02:03Z | 2014-27834 | 0 | 0 | 090000648194f380 |
| FDA-2011-N-0318-0002 | FDA | FDA-2011-N-0318 | Division of Freedom of Information; Change of Office Name, and Removal of Address, Telephone Number, and Fax Number; Technical Amendment | Rule | Final Rule | 2014-11-14T05:00:00Z | 2014 | 11 | 2014-11-14T05:00:00Z | 2014-11-17T15:47:31Z | 2014-26914 | 0 | 0 | 090000648192e745 | |
| FDA-2014-N-0002-0057 | FDA | FDA-2014-N-0002 | New Animal Drugs; Alfaxalone; Dinoprost; Ivermectin and Clorsulon; Nitrofurazone; Trenbolone and Estradiol Benzoate; Trimethoprim and Sulfadiazine; Tylosin; Change of Sponsor | Rule | Final Rule | 2014-10-28T04:00:00Z | 2014 | 10 | 2014-10-28T04:00:00Z | 2014-10-28T15:22:07Z | 2014-25588 | 0 | 0 | 09000064819017a0 | |
| FDA-2014-N-1440-0001 | FDA | FDA-2014-N-1440 | Medical Devices; Immunology and Microbiology Devices; Classification of Nucleic Acid-Based Devices for the Detection of Mycobacterium Tuberculosis Complex and the Genetic Mutations Associated With Antibiotic Resistance | Rule | Final Rule | 2014-10-22T04:00:00Z | 2014 | 10 | 2014-10-22T04:00:00Z | 2014-10-23T20:41:50Z | 2014-25049 | 0 | 0 | 09000064818e8424 | |
| FDA-2014-N-1251-0001 | FDA | FDA-2014-N-1251 | Medical Devices; Immunology and Microbiology Devices; Classification of Tryptase Test System | Rule | Final Rule | 2014-09-18T04:00:00Z | 2014 | 9 | 2014-09-18T04:00:00Z | 2014-09-18T14:57:02Z | 2014-22254 | 0 | 0 | 090000648187b61a | |
| FDA-2014-N-1166-0001 | FDA | FDA-2014-N-1166 | Medical Devices; Immunology and Microbiology Devices; Classification of Dengue Virus Nucleic Acid Amplification Test Reagents | Rule | Final Rule | 2014-09-10T04:00:00Z | 2014 | 9 | 2014-09-10T04:00:00Z | 2014-09-10T16:02:26Z | 2014-21479 | 0 | 0 | 0900006481868418 | |
| FDA-2008-N-0334-0014 | FDA | FDA-2008-N-0334 | Postmarketing Safety Reports for Human Drug and Biological Products; Electronic Submission Requirements; Corrections | Rule | Correction | 2014-09-08T04:00:00Z | 2014 | 9 | 2014-09-08T04:00:00Z | 2015-03-08T17:22:10Z | 2014-21267 | 0 | 0 | 090000648186336a | |
| FDA-2008-N-0334-0013 | FDA | FDA-2008-N-0334 | Postmarketing Safety Reports for Human Drug and Biological Products; Electronic Submission Requirements; Correction | Rule | Correction | 2014-09-08T04:00:00Z | 2014 | 9 | 2014-09-08T04:00:00Z | 2015-03-08T17:22:21Z | 2014-21266 | 0 | 0 | 09000064818633f4 | |
| FDA-2014-N-0002-0044 | FDA | FDA-2014-N-0002 | New Animal Drugs; Buprenorphine; Carprofen; Danofloxacin; Follicle Stimulating Hormone; Ractopamine; Salinomycin; Tylosin | Rule | Final Rule | 2014-09-08T04:00:00Z | 2014 | 9 | 2014-09-08T04:00:00Z | 2014-09-08T16:53:36Z | 2014-20325 | 0 | 0 | 09000064818632fd | |
| FDA-2014-N-1176-0001 | FDA | FDA-2014-N-1176 | Medical Devices; Hematology and Pathology Devices; Classification of Early Growth Response 1 Gene Fluorescence In-Situ Hybridization Test System for Specimen Characterization | Rule | Final Rule | 2014-09-03T04:00:00Z | 2014 | 9 | 2014-09-03T04:00:00Z | 2014-09-03T14:16:25Z | 2014-20882 | 0 | 0 | 0900006481857f13 | |
| FDA-2014-N-0011-0002 | FDA | FDA-2014-N-0011 | Medical Devices; Technical Amendment | Rule | Final Rule | 2014-08-25T04:00:00Z | 2014 | 8 | 2014-08-25T04:00:00Z | 2014-08-25T16:27:38Z | 2014-20107 | 0 | 0 | 0900006481841c3a | |
| FDA-2014-N-1112-0001 | FDA | FDA-2014-N-1112 | Medical Devices; Clinical Chemistry and Clinical Toxicology Devices; Classification of Hemoglobin A1c Test System | Rule | Final Rule | 2014-08-25T04:00:00Z | 2014 | 8 | 2014-08-25T04:00:00Z | 2014-08-25T16:33:06Z | 2014-20022 | 0 | 0 | 090000648184229c | |
| FDA-2012-F-0138-0007 | FDA | FDA-2012-F-0138 | Food Additives Permitted for Direct Addition to Food for Human Consumption; Vitamin D3 | Rule | Final Rule | 2014-08-12T04:00:00Z | 2014 | 8 | 2014-08-12T04:00:00Z | 2014-09-12T03:59:59Z | 2014-09-12T01:03:39Z | 2014-18969 | 0 | 0 | 090000648181b8d8 |
| FDA-2014-N-0002-0040 | FDA | FDA-2014-N-0002 | New Animal Drugs; Bacitracin Methylene Disalicylate; Dinoprost Solution; Gonadorelin Hydrochloride; Progesterone Intravaginal Inserts; Salinomycin; Ractopamine; Tylosin | Rule | Final Rule | 2014-07-31T04:00:00Z | 2014 | 7 | 2014-07-31T04:00:00Z | 2014-07-31T14:23:56Z | 2014-17912 | 0 | 0 | 09000064817f160d | |
| FDA-2012-N-0303-0005 | FDA | FDA-2012-N-0303 | Medical Devices: Gastroenterology-Urology Devices; Implanted Blood Access Devices; Reclassification | Rule | Final Rule | 2014-07-25T04:00:00Z | 2014 | 7 | 2014-07-25T04:00:00Z | 2014-07-28T12:32:21Z | 2014-17477 | 0 | 0 | 09000064817e1570 | |
| FDA-2014-M-0966-0001 | FDA | FDA-2014-M-0966 | Medical Devices; Gastroenterology- Urology Devices; Classification of the Implantable Transprostatic Tissue Retractor System | Rule | Final Rule | 2014-07-25T04:00:00Z | 2014 | 7 | 2014-07-25T04:00:00Z | 2014-07-28T11:47:31Z | 2014-17542 | 0 | 0 | 09000064817e1658 | |
| FDA-1995-N-0063-0077 | FDA | CGMPs for the Production of Infant Formula FDA-1995-N-0063 | Current Good Manufacturing Practices, Quality Control Procedures, Quality Factors, Notification Requirements, and Records and Reports, for Infant Formula; Correction | Rule | Correction | 2014-07-15T04:00:00Z | 2014 | 7 | 2014-07-15T04:00:00Z | 2014-07-15T14:43:19Z | 2014-16476 | 0 | 0 | 09000064817ad884 | |
| FDA-2012-N-0920-0013 | FDA | FDA-2012-N-0920 | Tobacco Products, User Fees, Requirements for the Submission of Data Needed To Calculate User Fees for Domestic Manufacturers and Importers of Tobacco Products | Rule | Final Rule | 2014-07-10T04:00:00Z | 2014 | 7 | 2014-07-10T04:00:00Z | 2014-07-10T13:49:44Z | 2014-16153 | 0 | 0 | 090000648179ccd9 | |
| FDA-2014-M-0850-0001 | FDA | FDA-2014-M-0850 | Medical Devices; Neurological Devices; Classification of the Transcranial Magnetic Stimulator for Headache | Rule | Final Rule | 2014-07-08T04:00:00Z | 2014 | 7 | 2014-07-08T04:00:00Z | 2014-07-08T15:22:21Z | 2014-15876 | 0 | 0 | 0900006481796958 | |
| FDA-2014-M-0701-0001 | FDA | FDA-2014-M-0701 | Medical Devices; Physical Medicine Devices; Classification of the Nonpowered Lower Extremity Pressure Wrap | Rule | Final Rule | 2014-07-03T04:00:00Z | 2014 | 7 | 2014-07-03T04:00:00Z | 2014-07-03T14:08:45Z | 2014-15626 | 0 | 0 | 090000648178e9fb | |
| FDA-2014-M-0799-0001 | FDA | FDA-2014-M-0799 | Medical Devices; Neurological Devices; Classification of the Transcutaneous Electrical Nerve Stimulator to Treat Headache | Rule | Final Rule | 2014-07-03T04:00:00Z | 2014 | 7 | 2014-07-03T04:00:00Z | 2014-07-03T13:52:55Z | 2014-15625 | 0 | 0 | 090000648178ea83 | |
| FDA-2014-N-0002-0025 | FDA | FDA-2014-N-0002 | New Animal Drugs for Use in Animal Feeds; Chlortetracycline and Sulfamethazine; Chlortetracycline; Procaine Penicillin; and Sulfamethazine | Rule | Final Rule | 2014-07-02T04:00:00Z | 2014 | 7 | 2014-07-02T04:00:00Z | 2014-07-02T14:32:37Z | 2014-15274 | 0 | 0 | 09000064817870be | |
| FDA-2014-N-0002-0026 | FDA | FDA-2014-N-0002 | Withdrawal of Approval of Part of a New Animal Drug Application; Procaine Penicillin | Rule | Withdrawal | 2014-07-02T04:00:00Z | 2014 | 7 | 2014-07-02T04:00:00Z | 2015-03-23T18:12:15Z | 2014-15273 | 0 | 0 | 0900006481786fc6 | |
| FDA-2014-N-0002-0027 | FDA | FDA-2014-N-0002 | New Animal Drugs; Afoxalaner; Ceftiofur Crystalline Free Acid; Chloramine-T; Clodronate; Enrofloxacin; Eprinomectin; Fluralaner; Ivermectin and Praziquantel; Niclosamide; Ractopamine; Tylosin; Change of Sponsor’s Address | Rule | Final Rule | 2014-07-02T04:00:00Z | 2014 | 7 | 2014-07-02T04:00:00Z | 2014-07-02T15:34:44Z | 2014-15276 | 0 | 0 | 0900006481787238 | |
| FDA-2014-N-0108-0003 | FDA | FDA-2014-N-0108 | New Animal Drug Applications; Confidentiality of Data and Information in a New Animal Drug Application File; Confirmation of Effective Date | Rule | Direct Final Rule | 2014-07-01T04:00:00Z | 2014 | 7 | 2014-07-01T04:00:00Z | 2014-07-01T17:42:55Z | 2014-15209 | 0 | 0 | 0900006481778777 | |
| FDA-2012-N-0677-0005 | FDA | FDA-2012-N-0677 | Dental Devices; Reclassification of Blade-Form Endosseous Dental Implant | Rule | Final Rule | 2014-06-18T04:00:00Z | 2014 | 6 | 2014-06-18T04:00:00Z | 2014-06-18T14:57:52Z | 2014-14216 | 0 | 0 | 090000648174fb90 | |
| FDA-2014-N-0655-0001 | FDA | FDA-2014-N-0655 | Medical Devices; General and Plastic Surgery Devices; Classification of the Nonabsorbable Expandable Hemostatic Sponge for Temporary Internal Use | Rule | Final Rule | 2014-06-16T04:00:00Z | 2014 | 6 | 2014-06-16T04:00:00Z | 2014-06-16T13:32:43Z | 2014-13905 | 0 | 0 | 0900006481749e85 | |
| FDA-2012-C-0900-0003 | FDA | FDA-2012-C-0900 | Listing of Color Additives Exempt From Certification; Spirulina Extract; Confirmation of Effective Date | Rule | Final Rule | 2014-06-11T04:00:00Z | 2014 | 6 | 2014-06-11T04:00:00Z | 2014-06-11T15:43:44Z | 2014-13524 | 0 | 0 | 090000648173a6ac | |
| FDA-2014-D-0033-0003 | FDA | FDA-2014-D-0033 | Guidance for Industry and Staff: Demonstration of the Quality Factor Requirements for Eligible Infant Formulas | Rule | Final Rule | 2014-06-10T04:00:00Z | 2014 | 6 | 2014-06-10T04:00:00Z | 2014-06-10T20:08:22Z | 2014-13386 | 0 | 0 | 0900006481735f79 | |
| FDA-2008-N-0334-0009 | FDA | FDA-2008-N-0334 | Postmarketing Safety Reports for Human Drug and Biological Products; Electronic Submission Requirements | Rule | Final Rule | 2014-06-10T04:00:00Z | 2014 | 6 | 2014-06-10T04:00:00Z | 2014-06-10T15:52:19Z | 2014-13480 | 0 | 0 | 0900006481734bb1 | |
| FDA-1995-N-0063-0049 | FDA | CGMPs for the Production of Infant Formula FDA-1995-N-0063 | Current Good Manufacturing Practices, Quality Control Procedures, Quality Factors, Notification Requirements, and Records and Reports, for Infant Formula | Rule | Final Rule | 2014-06-10T04:00:00Z | 2014 | 6 | 2014-06-10T04:00:00Z | 2014-07-11T03:59:59Z | 2014-07-03T01:01:55Z | 2014-13384 | 0 | 0 | 0900006481734cd4 |
| FDA-2012-S-0782-0047 | FDA | FDA-2012-S-0782 | See Document ID FDA-2014-D-0033-0003 for the Correct Federal Register Document for Comment Participation | Rule | Correction | 2014-06-10T04:00:00Z | 2014 | 6 | 2014-06-10T04:00:00Z | 2015-10-19T20:11:56Z | 0 | 0 | 0900006481734c4e | ||
| FDA-2014-N-0113-0004 | FDA | FDA-2014-N-0113 | Maximum Civil Money Penalty Amounts; Civil Money Penalty Complaints; Confirmation of Effective Date | Rule | Direct Final Rule | 2014-06-06T04:00:00Z | 2014 | 6 | 2014-06-06T04:00:00Z | 2014-06-06T14:05:17Z | 2014-13165 | 0 | 0 | 090000648172ce0b | |
| FDA-2012-N-1037-0030 | FDA | FDA-2012-N-1037 | Establishing a List of Qualifying Pathogens Under the Food and Drug Administration Safety and Innovation Act | Rule | Final Rule | 2014-06-05T04:00:00Z | 2014 | 6 | 2014-06-05T04:00:00Z | 2014-06-05T14:39:54Z | 2014-13023 | 0 | 0 | 090000648172a9f3 | |
| FDA-2014-N-0576-0001 | FDA | FDA-2014-N-0576 | Medical Devices; General and Plastic Surgery Devices; Classification of the Powered Surgical Instrument for Improvement in the Appearance of Cellulite | Rule | Final Rule | 2014-06-03T04:00:00Z | 2014 | 6 | 2014-06-03T04:00:00Z | 2014-06-03T15:15:15Z | 2014-12814 | 0 | 0 | 0900006481725e5c | |
| FDA-2013-N-0461-1589 | FDA | FDA-2013-N-0461 | General and Plastic Surgery Devices: Reclassification of Ultraviolet Lamps for Tanning, Henceforth To Be Known as Sunlamp Products and Ultraviolet Lamps Intended for Use in Sunlamp Products | Rule | Final Rule | 2014-06-02T04:00:00Z | 2014 | 6 | 2014-06-02T04:00:00Z | 2016-07-13T01:00:34Z | 2014-12546 | 0 | 0 | 0900006481722b4c | |
| FDA-2013-N-0544-0002 | FDA | FDA-2013-N-0544 | Microbiology Devices; Reclassification of Nucleic Acid-Based Systems for Mycobacterium tuberculosis Complex in Respiratory Specimens | Rule | Final Rule | 2014-05-30T04:00:00Z | 2014 | 5 | 2014-05-30T04:00:00Z | 2014-05-30T17:45:26Z | 2014-12544 | 0 | 0 | 090000648171f527 | |
| FDA-2014-N-0429-0001 | FDA | FDA-2014-N-0429 | Medical Devices; Immunology and Microbiology Devices; Classification of Dengue Virus Serological Reagents | Rule | Final Rule | 2014-05-30T04:00:00Z | 2014 | 5 | 2014-05-30T04:00:00Z | 2014-05-30T14:48:44Z | 2014-12545 | 0 | 0 | 090000648171f1e5 | |
| FDA-2013-N-0365-0007 | FDA | FDA-2013-N-0365 | Administrative Detention of Drugs Intended for Human or Animal Use | Rule | Final Rule | 2014-05-29T04:00:00Z | 2014 | 5 | 2014-05-29T04:00:00Z | 2014-05-29T15:59:16Z | 2014-12458 | 0 | 0 | 090000648171b9a2 | |
| FDA-2014-N-0430-0001 | FDA | FDA-2014-N-0430 | Medical Devices; Gastroenterology- Urology Devices; Classification of Pancreatic Drainage Stent and Delivery System | Rule | Final Rule | 2014-05-29T04:00:00Z | 2014 | 5 | 2014-05-29T04:00:00Z | 2014-05-29T16:09:36Z | 2014-12297 | 0 | 0 | 090000648171b99c | |
| FDA-2009-F-0303-0008 | FDA | FDA-2009-F-0303 | Food Additives Permitted for Direct Addition to Food for Human Consumption; Advantame | Rule | Final Rule | 2014-05-21T04:00:00Z | 2014 | 5 | 2014-05-21T04:00:00Z | 2014-06-21T03:59:59Z | 2014-06-21T01:01:52Z | 2014-11584 | 0 | 0 | 0900006481708a3c |
| FDA-2014-N-0002-0024 | FDA | FDA-2014-N-0002 | Oral Dosage Form New Animal Drugs; Change of Sponsor | Rule | Final Rule | 2014-05-20T04:00:00Z | 2014 | 5 | 2014-05-20T04:00:00Z | 2014-05-20T14:44:54Z | 2014-10415 | 0 | 0 | 09000064817056d1 | |
| FDA-2014-N-0438-0001 | FDA | FDA-2014-N-0438 | Medical Devices; General Hospital and Personal Use Devices; Classification of the Intravascular Administration Set, Automated Air Removal System | Rule | Final Rule | 2014-05-16T04:00:00Z | 2014 | 5 | 2014-05-16T04:00:00Z | 2014-05-16T16:00:01Z | 2014-11174 | 0 | 0 | 09000064816ff2b4 | |
| FDA-2014-N-0431-0001 | FDA | FDA-2014-N-0431 | Medical Devices; Gastroenterology- Urology Devices; Classification of the Colon Capsule Imaging System | Rule | Final Rule | 2014-05-16T04:00:00Z | 2014 | 5 | 2014-05-16T04:00:00Z | 2014-05-16T15:52:17Z | 2014-11173 | 0 | 0 | 09000064816ff2b7 | |
| FDA-2005-P-0371-0029 | FDA | Nutrient Content Claims for ALA & DHA Omega-3 Fatty Acids FDA-2005-P-0371 | Food Labeling: Nutrient Content Claims; Alpha-Linolenic Acid, Eicosapentaenoic Acid, and Docosahexaenoic Acid Omega-3 Fatty Acids | Rule | Final Rule | 2014-04-29T04:00:00Z | 2014 | 4 | 2014-04-29T04:00:00Z | 2014-04-29T19:41:03Z | 2014-09492 | 0 | 0 | 09000064816d5c49 | |
| FDA-2004-N-0382-0036 | FDA | Nutrient content claims: DHA, EPA, and ALA (Omega-3 Fatty Acids) FDA-2004-N-0382 | Food Labeling: Nutrient Content Claims; Alpha-Linolenic Acid, Eicosapentaenoic Acid, and Docosahexaenoic Acid Omega-3 Fatty Acids | Rule | Final Rule | 2014-04-29T04:00:00Z | 2014 | 4 | 2014-04-29T04:00:00Z | 2014-04-29T19:39:53Z | 2014-09492 | 0 | 0 | 09000064816d5bde | |
| FDA-2006-P-0224-0029 | FDA | Nutrient Content Claim for EPA and DHA omega-3 fatty acids FDA-2006-P-0224 | Food Labeling: Nutrient Content Claims; Alpha-Linolenic Acid, Eicosapentaenoic Acid, and Docosahexaenoic Acid Omega-3 Fatty Acids | Rule | Final Rule | 2014-04-29T04:00:00Z | 2014 | 4 | 2014-04-29T04:00:00Z | 2014-04-29T19:41:54Z | 2014-09492 | 0 | 0 | 09000064816d5c50 | |
| FDA-2007-0601-0021 | FDA | FDA-2007-0601 | Food Labeling: Nutrient Content Claims; Alpha-Linolenic Acid, Eicosapentaenoic Acid, and Docosahexaenoic Acid Omega-3 Fatty Acids | Rule | Final Rule | 2014-04-28T04:00:00Z | 2014 | 4 | 2014-04-28T04:00:00Z | 2014-04-29T19:29:01Z | 2014-09492 | 0 | 0 | 09000064816d1619 | |
| FDA-2013-N-0069-0004 | FDA | FDA-2013-N-0069 | Medical Devices; Ophthalmic Devices; Classification of the Eyelid Weight | Rule | Final Rule | 2014-04-21T04:00:00Z | 2014 | 4 | 2014-04-21T04:00:00Z | 2014-04-21T13:51:14Z | 2014-08940 | 0 | 0 | 09000064816bdd6d | |
| FDA-2014-N-0002-0021 | FDA | FDA-2014-N-0002 | New Animal Drugs; Ceftiofur Sodium; Gentamicin; Xylazine | Rule | Final Rule | 2014-04-15T04:00:00Z | 2014 | 4 | 2014-04-15T04:00:00Z | 2014-04-15T15:35:02Z | 2014-08445 | 0 | 0 | 09000064816b3fde | |
| FDA-2001-F-0049-0003 | FDA | Foodborne pathogens in raw-frozen-cooked-partially cooked FDA-2001-F-0049 | Irradiation in the Production, Processing and Handling of Food | Rule | Final Rule | 2014-04-14T04:00:00Z | 2014 | 4 | 2014-04-14T04:00:00Z | 2014-05-15T03:59:59Z | 2014-05-03T01:05:00Z | 2014-07926 | 0 | 0 | 09000064816b1fb5 |
| FDA-2013-N-0568-0029 | FDA | FDA-2013-N-0568 | Physical Medicine Devices; Reclassification of Stair-Climbing Wheelchairs | Rule | Final Rule | 2014-04-14T04:00:00Z | 2014 | 4 | 2014-04-14T04:00:00Z | 2014-04-14T14:35:14Z | 2014-08257 | 0 | 0 | 09000064816b252a | |
| FDA-2014-N-0355-0001 | FDA | FDA-2014-N-0355 | Advisory Committee: Bone, Reproductive and Urologic Drugs Advisory Committee | Rule | Final Rule | 2014-04-11T04:00:00Z | 2014 | 4 | 2014-04-11T04:00:00Z | 2014-04-11T15:36:46Z | 2014-08151 | 0 | 0 | 09000064816af6b1 | |
| FDA-2012-C-0900-0002 | FDA | FDA-2012-C-0900 | Listing of Color Additives Exempt From Certification; Spirulina Extract | Rule | Final Rule | 2014-04-11T04:00:00Z | 2014 | 4 | 2014-04-11T04:00:00Z | 2014-05-13T03:59:59Z | 2014-04-11T16:16:54Z | 2014-08099 | 0 | 0 | 09000064816af717 |
| FDA-2014-N-0002-0019 | FDA | FDA-2014-N-0002 | New Animal Drugs for Use in Animal Feeds; Withdrawal of Approval of New Animal Drug Applications; Bambermycins; Hygromycin B; Lincomycin; Pyrantel; Tylosin; Tylosin and Sulfamethazine; Virginiamycin | Rule | Final Rule | 2014-04-10T04:00:00Z | 2014 | 4 | 2014-04-10T04:00:00Z | 2015-03-23T19:18:47Z | 2014-08011 | 0 | 0 | 09000064816ad8a9 | |
| FDA-2014-N-0002-0020 | FDA | FDA-2014-N-0002 | Withdrawal of Approval of New Animal Drug Applications; Bambermycins; Hygromycin B; Lincomycin; Pyrantel; Tylosin; Tylosin and Sulfamethazine; Virginiamycin | Rule | Withdrawal | 2014-04-10T04:00:00Z | 2014 | 4 | 2014-04-10T04:00:00Z | 2015-03-23T19:19:01Z | 2014-08010 | 0 | 0 | 09000064816ad857 | |
| FDA-2014-N-0002-0018 | FDA | FDA-2014-N-0002 | Zoetis Inc., et al.; Withdrawal of Approval of New Animal Drug Applications for Combination Drug Medicated Feeds Containing an Arsenical Drug; Correction | Rule | Withdrawal | 2014-04-07T04:00:00Z | 2014 | 4 | 2014-04-07T04:00:00Z | 2015-03-23T19:18:32Z | 2014-07702 | 0 | 0 | 09000064816a301d | |
| FDA-2002-N-0153-0133 | FDA | Bioterrorism; Establishment & Maintenance of Records FDA-2002-N-0153 | Establishment, Maintenance, and Availability of Records: Amendment to Record Availability Requirements | Rule | Final Rule | 2014-04-04T04:00:00Z | 2014 | 4 | 2014-04-04T04:00:00Z | 2014-04-04T13:52:42Z | 2014-07550 | 0 | 0 | 090000648169d694 | |
| FDA-2011-D-0674-0043 | FDA | FDA-2011-D-0674 | Guidance for Industry: Food and Drug Administration Records Access Authority Under the Federal Food, Drug, and Cosmetic Act; Availability | Rule | Notice of Availability | 2014-04-04T04:00:00Z | 2014 | 4 | 2014-04-04T04:00:00Z | 2014-04-07T16:40:47Z | 2014-07551 | 0 | 0 | 090000648169ddb1 | |
| FDA-2013-N-0002-0050 | FDA | FDA-2013-N-0002 | New Animal Drugs; Amprolium; Bambermycins; Ceftiofur; Deslorelin; Florfenicol; Florfenicol and Flunixin; Paclitaxel; Phenylbutazone; Pimobendan; Salinomycin; Tilmicosin; Tiludronate; Change of Sponsor | Rule | Final Rule | 2014-04-01T04:00:00Z | 2014 | 4 | 2014-04-01T04:00:00Z | 2014-04-01T13:05:54Z | 2014-07220 | 0 | 0 | 0900006481694311 | |
| FDA-2014-N-0002-0017 | FDA | FDA-2014-N-0002 | Zoetis Inc., et al.; Withdrawal of Approval of New Animal Drug Applications for Combination Drug Medicated Feeds Containing an Arsenical Drug; Correction | Rule | Correction | 2014-03-31T04:00:00Z | 2014 | 3 | 2014-03-31T04:00:00Z | 2014-03-31T14:56:48Z | 2014-06994 | 0 | 0 | 0900006481691487 | |
| FDA-2014-N-0002-0016 | FDA | FDA-2014-N-0002 | Implantation or Injectable Dosage Form New Animal Drugs; Change of Sponsor | Rule | Final Rule | 2014-03-25T04:00:00Z | 2014 | 3 | 2014-03-25T04:00:00Z | 2014-03-25T13:46:05Z | 2014-06131 | 0 | 0 | 090000648167c94b | |
| FDA-2014-N-0002-0015 | FDA | FDA-2014-N-0002 | Withdrawal of Approval of New Animal Drug Applications; Chlortetracycline; Sulfathiazole; Penicillin | Rule | Withdrawal | 2014-03-20T04:00:00Z | 2014 | 3 | 2014-03-20T04:00:00Z | 2015-03-23T19:18:14Z | 2014-05883 | 0 | 0 | 0900006481671842 | |
| FDA-2014-N-0002-0014 | FDA | FDA-2014-N-0002 | Zoetis Inc., Withdrawal of Approval of New Animal Drug Applications; Chlortetracycline; Sulfathiazole; Penicillin | Rule | Final Rule | 2014-03-20T04:00:00Z | 2014 | 3 | 2014-03-20T04:00:00Z | 2014-03-20T14:12:00Z | 2014-05882 | 0 | 0 | 09000064816718df | |
| FDA-2014-N-0108-0002 | FDA | FDA-2014-N-0108 | New Animal Drug Applications; Confidentiality of Data and Information in a New Animal Drug Application File | Rule | Direct Final Rule | 2014-03-17T04:00:00Z | 2014 | 3 | 2014-03-17T04:00:00Z | 2014-06-03T03:59:59Z | 2014-07-01T17:41:20Z | 2014-05430 | 0 | 0 | 090000648166a7cf |
| FDA-2012-F-1100-0003 | FDA | FDA-2012-F-1100 | Food Additives Permitted in Feed and Drinking Water of Animals; Benzoic Acid | Rule | Final Rule | 2014-03-13T04:00:00Z | 2014 | 3 | 2014-03-13T04:00:00Z | 2014-04-15T03:59:59Z | 2014-04-12T01:01:45Z | 2014-05440 | 0 | 0 | 0900006481663885 |
| FDA-2014-N-0002-0005 | FDA | FDA-2014-N-0002 | New Animal Drugs; Change of Sponsor | Rule | Final Rule | 2014-03-11T04:00:00Z | 2014 | 3 | 2014-03-11T04:00:00Z | 2014-03-11T14:44:15Z | 2014-04937 | 0 | 0 | 090000648165dc9a | |
| FDA-2009-F-0570-0005 | FDA | FDA-2009-F-0570 | Food Additives Permitted for Direct Addition to Food for Human Consumption; Vitamin D2 Bakers Yeast | Rule | Final Rule | 2014-03-11T04:00:00Z | 2014 | 3 | 2014-03-11T04:00:00Z | 2014-03-11T13:58:28Z | 2014-05060 | 0 | 0 | 090000648165e10a | |
| FDA-2014-N-0107-0001 | FDA | FDA-2014-N-0107 | Medical Devices; General and Plastic Surgery Devices; Classification of the Absorbable Lung Biopsy Plug | Rule | Final Rule | 2014-03-10T04:00:00Z | 2014 | 3 | 2014-03-10T04:00:00Z | 2014-03-10T17:30:36Z | 2014-05061 | 0 | 0 | 090000648165ab2d | |
| FDA-2014-N-0002-0004 | FDA | FDA-2014-N-0002 | Zoetis Inc., et al.; Withdrawal of Approval of New Animal Drug Applications for Combination Drug Medicated Feeds Containing an Arsenical Drug | Rule | Withdrawal | 2014-02-27T05:00:00Z | 2014 | 2 | 2014-02-27T05:00:00Z | 2015-03-23T19:17:47Z | 2014-02616 | 0 | 0 | 09000064815d82c7 | |
| FDA-2014-N-0002-0002 | FDA | FDA-2014-N-0002 | New Animal Drugs; Change of Sponsor | Rule | Final Rule | 2014-02-27T05:00:00Z | 2014 | 2 | 2014-02-27T05:00:00Z | 2015-03-23T19:17:10Z | 2014-01958 | 0 | 0 | 09000064815d85cf | |
| FDA-2014-N-0002-0001 | FDA | FDA-2014-N-0002 | New Animal Drugs; Bambermycins; Clopidol; Ivermectin; Penicillin G Procaine and Dihydrostreptomycin Sulfate; Progesterone; Robenicoxib; Sulfadimethoxine; Change of Sponsor; Change of Sponsor’s Address | Rule | Final Rule | 2014-02-27T05:00:00Z | 2014 | 2 | 2014-02-27T05:00:00Z | 2015-03-23T19:16:55Z | 2014-01959 | 0 | 0 | 09000064815d861b | |
| FDA-2014-N-0002-0003 | FDA | FDA-2014-N-0002 | Zoetis Inc., et al.; Withdrawal of Approval of New Animal Drug Applications for Combination Drug Medicated Feeds Containing an Arsenical Drug | Rule | Final Rule | 2014-02-27T05:00:00Z | 2014 | 2 | 2014-02-27T05:00:00Z | 2015-03-23T19:17:31Z | 2014-02617 | 0 | 0 | 09000064815d82c8 | |
| FDA-1999-F-2405-1301 | FDA | Use of Ionizing Radiation for the Control of Food-Borne Pathogens and Infectious Protozoa, and Extension of Shelf-Life, in a Variety of Human Foods. FDA-1999-F-2405 | Irradiation in the Production, Processing, and Handling of Food | Rule | Final Rule | 2014-02-25T05:00:00Z | 2014 | 2 | 2014-02-25T05:00:00Z | 2014-02-25T21:25:50Z | 2014-03976 | 0 | 0 | 09000064815b1509 | |
| FDA-1977-N-0222-0001 | FDA | Medical Devices; Administrative Detention Procedures FDA-1977-N-0222 | Administrative Detention; Corrections | Rule | Correction | 2014-02-19T05:00:00Z | 2014 | 2 | 2014-02-19T05:00:00Z | 2014-02-19T17:04:12Z | 2014-03582 | 0 | 0 | 0900006481581ae6 | |
| FDA-1995-N-0063-0017 | FDA | CGMPs for the Production of Infant Formula FDA-1995-N-0063 | Current Good Manufacturing Practices, Quality Control Procedures, Quality Factors, Notification Requirements, and Records and Reports, for Infant Formula; Correction | Rule | Correction | 2014-02-19T05:00:00Z | 2014 | 2 | 2014-02-19T05:00:00Z | 2014-02-19T16:40:15Z | 2014-03588 | 0 | 0 | 0900006481581c6e | |
| FDA-2014-N-0011-0001 | FDA | FDA-2014-N-0011 | Medical Devices; Reports of Corrections and Removals; Technical Amendment | Rule | Final Rule | 2014-02-19T05:00:00Z | 2014 | 2 | 2014-02-19T05:00:00Z | 2014-02-19T17:42:38Z | 2014-03581 | 0 | 0 | 0900006481581b49 | |
| FDA-2013-M-0042-0002 | FDA | FDA-2013-M-0042 | Medical Devices; Neurological Devices; Classification of the Neuropsychiatric Interpretive Electroencephalograph Assessment Aid | Rule | Final Rule | 2014-02-18T05:00:00Z | 2014 | 2 | 2014-02-18T05:00:00Z | 2014-02-19T19:05:29Z | 2014-03388 | 0 | 0 | 0900006481576844 | |
| FDA-2008-N-0393-0013 | FDA | FDA-2008-N-0393 | Medical Device Reporting: Electronic Submission Requirements | Rule | Final Rule | 2014-02-14T05:00:00Z | 2014 | 2 | 2014-02-14T05:00:00Z | 2014-02-14T17:29:16Z | 2014-03279 | 0 | 0 | 09000064815663fd | |
| FDA-1995-N-0063-0014 | FDA | CGMPs for the Production of Infant Formula FDA-1995-N-0063 | Current Good Manufacturing Practices (CGMPs), Quality Control Procedures, Quality Factors, Notification Requirements, and Records and Reports, for Infant Formula | Rule | Interim Final Rule | 2014-02-10T05:00:00Z | 2014 | 2 | 2014-02-10T05:00:00Z | 2014-03-28T03:59:59Z | 2014-07-03T01:02:17Z | 2014-02148 | 0 | 0 | 0900006481556431 |
| FDA-2014-N-0113-0002 | FDA | FDA-2014-N-0113 | Maximum Civil Money Penalty Amounts; Civil Money Penalty Complaints | Rule | Final Rule | 2014-02-03T05:00:00Z | 2014 | 2 | 2014-02-03T05:00:00Z | 2014-04-22T03:59:59Z | 2014-04-01T01:03:43Z | 2014-02150 | 0 | 0 | 0900006481542d2e |
| FDA-2013-N-1662-0001 | FDA | FDA-2013-N-1662 | Medical Devices; Immunology and Microbiology Devices; Classification of John Cunningham Virus Serological Reagents | Rule | Final Rule | 2014-01-23T05:00:00Z | 2014 | 1 | 2014-01-23T05:00:00Z | 2014-01-23T17:11:01Z | 2014-01216 | 0 | 0 | 090000648151ce75 | |
| FDA-2013-N-0002-0048 | FDA | FDA-2013-N-0002 | Current Good Manufacturing Practice for Medicated Feeds | Rule | Final Rule | 2014-01-23T05:00:00Z | 2014 | 1 | 2014-01-23T05:00:00Z | 2014-01-23T17:39:42Z | 2014-01299 | 0 | 0 | 090000648151cdd1 | |
| FDA-2013-N-0195-0100 | FDA | FDA-2013-N-0195 | Effective Date of Requirement for Premarket Approval for Transilluminator for Breast Evaluation and Sorbent Hemoperfusion System (SHS) Devices for the Treatment of Hepatic Coma and Metabolic Disturbances; Reclassification of SHS Devices for the Treatment of Poisoning and Drug Overdose | Rule | Final Rule | 2014-01-17T05:00:00Z | 2014 | 1 | 2014-01-17T05:00:00Z | 2014-01-17T15:57:55Z | 2014-00873 | 0 | 0 | 0900006481510c9a | |
| FDA-2013-N-0002-0047 | FDA | FDA-2013-N-0002 | Withdrawal of Approval of New Animal Drug Applications; Argent Laboratories; Formalin; Tricaine Methanesulfonate | Rule | Final Rule | 2014-01-16T05:00:00Z | 2014 | 1 | 2014-01-16T05:00:00Z | 2014-01-16T15:17:57Z | 2014-00721 | 0 | 0 | 090000648150d6c6 | |
| FDA-2013-N-0002-0046 | FDA | FDA-2013-N-0002 | Withdrawal of Approval of New Animal Drug Applications; Argent Laboratories; Formalin; Tricaine Methanesulfonate | Rule | Withdrawal | 2014-01-16T05:00:00Z | 2014 | 1 | 2014-01-16T05:00:00Z | 2014-01-16T15:01:12Z | 2014-00722 | 0 | 0 | 090000648150d714 | |
| FDA-2013-N-1687-0001 | FDA | FDA-2013-N-1687 | Advisory Committee; Pharmacy Compounding Advisory Committee | Rule | Final Rule | 2014-01-13T05:00:00Z | 2014 | 1 | 2014-01-13T05:00:00Z | 2014-01-13T15:04:44Z | 2014-00322 | 0 | 0 | 090000648150369e | |
| FDA-2009-N-0458-0016 | FDA | FDA-2009-N-0458 | Medical Devices; Pediatric Uses of Devices; Requirement for Submission of Information on Pediatric Subpopulations That Suffer From a Disease or Condition That a Device Is Intended To Treat, Diagnose, or Cure. - CLOSED | Rule | Final Rule | 2014-01-10T05:00:00Z | 2014 | 1 | 2014-01-10T05:00:00Z | 2014-01-13T15:21:29Z | 2014-00267 | 0 | 0 | 09000064814fa981 |
Advanced export
JSON shape: default, array, newline-delimited, object
CREATE TABLE documents (
id TEXT PRIMARY KEY,
agency_id TEXT,
docket_id TEXT REFERENCES dockets(id),
title TEXT,
document_type TEXT,
subtype TEXT,
posted_date TEXT,
posted_year INTEGER,
posted_month INTEGER,
comment_start_date TEXT,
comment_end_date TEXT,
last_modified TEXT,
fr_doc_num TEXT,
open_for_comment INTEGER,
withdrawn INTEGER,
object_id TEXT
);
CREATE INDEX idx_docs_agency ON documents(agency_id);
CREATE INDEX idx_docs_docket ON documents(docket_id);
CREATE INDEX idx_docs_date ON documents(posted_date);
CREATE INDEX idx_docs_year ON documents(posted_year);
CREATE INDEX idx_docs_type ON documents(document_type);
CREATE INDEX idx_docs_frnum ON documents(fr_doc_num);